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Abstract 1 
Objective measures to diagnose and to monitor improvement of symptoms following mild 2 
traumatic brain injury (mTBI) are lacking. Computerized eye tracking has been advocated as a 3 
rapid, user friendly and field ready technique to meet this need. Eye tracking data collected via a 4 
head mounted, video-based binocular eye tracker was used to examine saccades, fixations and 5 
smooth pursuit movement in 60  military Service Members  with post concussive syndrome 6 
(PCS) and 26  asymptomatic control subjects in an effort to determine if eye movement 7 
differences could be found and quantified. The diagnosis of mTBI was confirmed by the study 8 
physiatrist’s history, physical examination, and a review of any medical records. Results 9 
demonstrated that subjects with symptomatic mTBI had statistically larger position errors, 10 
smaller saccadic amplitudes, smaller predicted peak velocities, smaller peak accelerations, and 11 
longer durations. Subjects with symptomatic mTBI were also less likely to follow a target 12 
movement (less primary saccades). In general, symptomatic mTBI tracked the stepwise moving 13 
targets less accurately, revealing possible brain dysfunction. A reliable, standardized protocol 14 
that appears to differentiate mTBI from normals was developed for use in future research. This 15 
investigation represents a step toward objective identification of those with PCS. Future studies 16 
focused on increasing the specificity of eye movement differences in those with PCS are needed. 17 
 18 
Key words: mild traumatic brain injury, post-concussion syndrome, eye tracking, saccades, 19 
fixations, smooth pursuit 20 
 21 
  22 
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Introduction 1 
As a result of injuries to both military servicemembers in combat and athletes in contact 2 
sports, there has been heightened focus on metrics to diagnose and monitor recovery after mild 3 
traumatic brain injury (mTBI) and related sequelae.
1,2
 A significant limiting factor in the 4 
diagnostic approach to mTBI has been the dependence on self-report of injury and symptoms, 5 
resulting in a provisional syndromic-based diagnosis, post-concussion syndrome (PCS). 6 
Increasingly there has been recognition that an mTBI is more accurately termed as a “potentially 7 
concussive event” (PCE), rather than a syndrome.3-5 If specific criteria (e.g., alteration or loss of 8 
consciousness with associated memory loss/amnesia surrounding the event) are confirmed, then 9 
the diagnosis of mTBI may be made. If these criteria are not met, then the PCE cannot be labeled 10 
as an mTBI, but may still manifest with symptoms related to secondary physical injury (e.g., 11 
neck or skull-based musculature and other soft-tissue) and psychological trauma (e.g., acute 12 
stress reaction). It is more proper to apply the “syndrome” label only after the mTBI has been 13 
confirmed and has manifest in a symptom complex that has persisted for more than three months 14 
after injury.
6
 Importantly, even in the case of a confirmed mTBI, the effects of other physical and 15 
psychological conditions often contribute to the symptoms and syndrome.
5 16 
The limitations of the current self-reported, subjective accounting of traumatic events, 17 
symptoms, and improvements are manifold. Without objective documentation of the PCE, such 18 
as pre-event neuropsychological screening, event videotaping, or data from accelerometers, these 19 
potential confounders include: altered or imprecise recall of event duration, severity, and date of 20 
occurrence, potentially inaccurate estimation of pre-event functioning, impact of acute stress 21 
response, and motivation (positive or negative) to accurately report symptoms. These factors are 22 
further influenced by the elapsed time between the event and medical assessment of the subject. 23 
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This is important at both the proximal (e.g., secondary factors surrounding the event or trauma 1 
that resulted in the PCE, acute recognition of PCE and/or mTBI, acute management of 2 
PCE/mTBI) and distal (e.g., increasing inaccuracy of precise recall weeks, months, or even years 3 
post-event, subsequent symptoms that arise after PCE, recognition, acknowledgement, and 4 
eventual assessment of the PCE/mTBI, ongoing management of the PCE and subsequent 5 
symptoms) ends of the encounter with the medical professional.  6 
 In addition to the use of self-reported injury events and post-injury symptoms, cognitive 7 
screens and more comprehensive neuropsychological testing have predominantly been utilized to 8 
diagnose and monitor recovery after mTBI. While this approach is well validated and has proven 9 
clinically useful, it also has a number of inherent limitations. Principal criticisms of the testing 10 
approach include the subjectivity of self-report, patient fatigue and motivation factors, practice 11 
effects, and influence of co-morbid conditions (e.g., pain, anxiety, depression, substance abuse). 12 
Additionally, testing batteries often vary in composition based on the practice patterns of 13 
individual clinicians, limiting the ability to compare across time and testing centers, with 14 
subsequent limitations on meaningful meta-analysis. There is no universally accepted 15 
neuropsychological testing battery after PCE. 16 
 There is increasing enthusiasm to rely on objective measures to determine the 17 
relationship of both a PCE to an mTBI and an mTBI to persistent symptoms. There are few well-18 
designed, large scale studies examining early brain changes following mTBI using diagnostic 19 
devices, although many devices and techniques for objectively measuring the brain have been 20 
proposed and examined.  Some involve measures of brain activity (e.g., electroencephalography 21 
[EEG], evoked responses)
7-9
, structure (diffusion tensor imaging [DTI], high density fiber 22 
tracking [HDFT])
10-12
,  hemodynamics (e.g., near-infrared spectroscopy [NIRS], transcranial 23 
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Doppler ultrasound [TCD])
13-15
, and functional testing (e.g., computerized posturography, 1 
computerized tests of cognition and executive function)
16-18
. Other efforts have focused on 2 
devices that attempt to measure intracranial pathology, such as intracranial hypertension via 3 
observation of extracranial phenomena (e.g., optic nerve sheath diameter [ONSD] or otoacoustic 4 
emissions).
19
 Despite the vigor of studying the utility and validity of these diagnostic approaches, 5 
none have achieved a level of efficacy to be considered as the “gold standard,” and 6 
multidimensional approaches using diagnostic algorithms have not been developed. 7 
One method for the objective assessment of the brain after PCE and mTBI that has shown 8 
promise as a user friendly, low cost, non-invasive, definitive approach is eye tracking. Eye 9 
tracking has been advocated as a rapid, convenient, and portable (i.e., field ready) method of 10 
evaluation However, specific research on its specificity and sensitivity is sparse in this 11 
population. Although specific values are not universally presented,
20
 one study suggested that the 12 
sensitivity and specificity of eye tracking paradigms reaches 100% when differentiating controls 13 
from mTBI, or even differentiating PCS from non-PCS in a suspected mTBI population.
21
  These 14 
results have not been replicated. Previous reports have shown the primary oculomotor deficits in 15 
mTBI to be difficulty reading (oculomotor specific), vergence, accommodation, and saccadic 16 
gain abnormalities.
22
 Eye tracking assessment typically involves the examination of saccades, 17 
fixation, and smooth pursuit eye movements (SPEM). Saccades (rapid, accurate, ballistic shifting 18 
of gaze to a new area of interest) are studied because they require the complex coordination and 19 
timing of neural circuitry in numerous different brain areas, including primarily the frontal lobe, 20 
basal ganglia, superior colliculus, and the cerebellum; and would therefore be likely to be 21 
sensitive indicators of injury to one of these areas.
23
 Further, the various parameters (e.g. 22 
direction, gain, velocity, trajectory, etc.) of saccades are “programmed” independent of each 23 
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other, generally free of cognitive influence, and can be studied both separately and in 1 
combination.
23
  Up to the present, fixation (maintaining an image of interest on the fovea) data 2 
have not been well studied in TBI patients, largely due to the technical challenges in measuring 3 
fixations, and the prevailing belief that the fixations themselves are “silent,’ offering no 4 
meaningful data. Fortunately, the technological limitations have been largely overcome with the 5 
latest generation of measurement tools and applied analyses. The “silent” nature of fixation 6 
deficits seems likely more an under appreciation of the linkage between subtle (often difficult to 7 
measure) visual processing deficits and a range of functional tasks (e.g., reading, driving) or 8 
somatic complaints (e.g., headache, dizziness). SPEM have been examined in this population, 9 
and while typically felt to be an important component of the visual complaints that are frequently 10 
voiced by individuals with persistent symptoms, studying this association has been met with 11 
equivocal results.
24
 Given the importance of vision and the visual system to humans, the 12 
frequency of post-concussive symptoms that may be attributed to the visual system, suggestions 13 
of linkages in prior research and  advances in eye tracking technology and analyses, further 14 
research into the use of techniques to study eye movements after mTBI is warranted. 15 
This study examined the utility of a standardized eye tracking protocol to differentiate 16 
individuals with self-reported, chronic effects of mTBI from symptom-free individuals without a 17 
reported history of mTBI. For this investigation, we hypothesized that there would be significant 18 
injury-related differences in saccades, fixational, and SPEM eye movements between 19 
symptomatic individuals and controls. If present, these differential findings could be used to 20 
differentiate between individuals who have sustained an mTBI versus those who have not. 21 
Additionally, it is the first step in a potentially differentiate individuals with focused symptoms 22 
related to mTBI and those more likely due to other causes or co-morbid conditions. 23 
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 1 
Methods 2 
This study received all appropriate institutional review board and governmental approvals.  For 3 
this study, 60 subjects with PCS (Group A), who were part of a larger Department of Defense 4 
clinical trial, were recruited primarily from United States military bases and 26 normal controls 5 
(Group B) were recruited from an academic medical center. All subjects were evaluated by a TBI 6 
research team, led by a physiatrist (DXC), and a positive or negative history of TBI was 7 
ascertained. The diagnosis of TBI was confirmed by the study physiatrist’s history, physical 8 
examination, and a review of any medical records for the subjects. Post-concussive symptoms, if 9 
present, were documented using the Rivermead Postconcussive Symptom Questionnaire 10 
(RPQ).
27
The RPQ is a widely used Likert-type symptom inventory consisting of 16 items [rated 11 
from 0 (never a problem) to 4 (severe problem)], designed to evaluate the somatic, cognitive and 12 
emotional functioning of individuals who have sustained a concussion. Whether part of the RPQ 13 
administration (subjects with mTBI) or via direct questioning, all subjects were questioned as to 14 
whether they had any subjective visual complaints, such as blurred vision, double vision, or 15 
floaters.  16 
A head mounted video-based binocular eye tracker (Eyelink II, SR Research, Kanata, 17 
Ontario, CAN) was used to record horizontal and vertical binocular gaze data at 500 samples per 18 
second. To minimize head movement, the subject’s head was supported by an adjustable chin 19 
rest cup.  Stimuli covering ±20° horizontally and ±13° vertically were presented at 120 Hz on a 20 
24-in LCD monitor placed 75 cm from the subject’s eyes in a darkened room. The height of the 21 
monitor display was adjusted so that the center of the screen corresponded to the center of the 22 
pupillary plane. Calibration and validation of the eye tracker was performed at three points along 23 
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each cardinal axis immediately before recording commenced.  The target stimulus was a white 1 
annulus, sized to occupy 0.25° of visual angle, with a high-contrast center point of 0.1° presented 2 
on a black background. Stimuli consisted of random, unpredictable step target movements and 3 
smooth pursuit paradigms in both the horizontal and vertical directions.  Subjects were allowed 4 
to close their eyes and rest between each recording to prevent fatigue.  5 
Eye position data were analyzed through a multi-step process involving initial visual 6 
inspection of the eye position recordings, followed by the use of specialized automated analysis 7 
algorithms, and lastly visual confirmation of the automated measures.  In all trials, the horizontal 8 
and vertical positions of each eye were analyzed. During automated analysis, the criteria for 9 
detecting a saccade required that the amplitude of the movement was greater than ±0.1°, the 10 
duration of the saccade fell within a predetermined minimum and maximum time limit, and that 11 
the calculated velocity and acceleration values (based on a two-point central difference method) 12 
were greater than ±20°/s and ±400°/s
2
, respectively, but also did not exceed a set of 13 
predetermined upper limits (in absolute value) for both velocity and acceleration. Responses that 14 
failed to meet the detection criteria for a saccade could then be considered as smooth pursuit, 15 
fixation when the eye is relatively stable, or artifact.  If the response was considered artifact, the 16 
analysis program would identify and mark the data for further inspection.  For any saccadic eye 17 
movement, the time, location, and amplitude of the saccade, as well as, its direction, duration, 18 
peak velocity, and peak acceleration and deceleration reached during the movement were 19 
determined and stored in a measurement summary file for later statistical analysis. For trials 20 
involving step changes in target position, the response latency (the time between the onset of 21 
target movement and response) were measured and recorded.   The saccadic gain was calculated 22 
as the ratio between the amplitude of the primary saccade (first saccade after target movement) 23 
10 
 
and the displaced target amplitude (total change in target position).  As a measure of positioning 1 
accuracy, the number and amplitudes of any additional corrective saccades that occurred after the 2 
primary saccade were recorded, as well as the final position error between the target and the eye.  3 
The inter-saccadic interval (time between saccades) defined a period the affixation period, or 4 
potentially, the duration of smooth pursuit.  5 
Fixation is characterized by relatively stable eye position with movement that has low 6 
velocity, low acceleration and no directional trend.  During fixation, the length of time was 7 
recorded and several measures of stability were performed.  Stability measures included 8 
computation of the position variance, computation of the root mean square (RMS) of eye 9 
velocity, and determination of the mean and absolute mean velocity of the eyes during fixation.  10 
As an additional measure of stability, bivariate contour elliptical analysis (BCEA) was used to 11 
define the orientation, semi-major and semi-minor dimensions, and area (degs
2
) of an elliptical 12 
contour which captured 90 percent of the fixation data during fixation on the zero degree, center 13 
target position.  These same data were also applied to a discrete Fourier transform (DFT) which 14 
determiner the frequency content or spectrum during fixation.   15 
Smooth pursuit occurs when the velocity of the eye closely matches the direction and 16 
velocity of the target.  Velocity mismatches between eye and target result in position errors, 17 
which are corrected by saccadic intrusions.  During pursuit, the velocity of the eye is greater 18 
compared to fixation velocity, while the pursuit acceleration is far less than what occurs during a 19 
saccade.  During periods of smooth pursuit, the number of saccades, saccadic amplitude, and 20 
pursuit gain were determined.  Pursuit gain, defined as the ratio between the weighted mean eye 21 
velocity and target velocity, was determined without inclusion of any corrective saccades.  22 
 23 
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Results 1 
Statistical Analyses. All statistical analyses were conducted using SPSS Statistics version 21.0 2 
(IBM SPSS). Data were assessed for normality using the Shapiro-Wilk test. Parameters that were 3 
not normally distributed (i.e., Shapiro-Wilk P value>.05) were then log-transformed and 4 
rechecked for normality.  Independent-sample, unpaired, 2-tailed t-tests (on either original 5 
variables or log transformed variables) were conducted to assess for differences between Groups 6 
A and B. The Levene test for the equality of variances was calculated, and if the significance was 7 
found to be less than .05, equal variances were not assumed.  In many cases, the data did not give 8 
any indication that the populations were normal or even log-normal (predominantly because of 9 
outliers).  For these variables, we used the non-parametric Mann-Whitney U test for comparing 10 
independent samples.  For each task, data from the right eye were analyzed as no within group 11 
left-right eye differences were noted in the cohort. Given the challenges in normalizing all data, 12 
the number of subject measurement points varied from task to task. 13 
 14 
Descriptive Data. There were 60 research subjects with symptomatic mTBI (Group A) and 26 15 
control subjects without a history of TBI or symptoms (Group B). All Group A subjects were 16 
male and had a mean age of 23.2 years (SD=2.95). Two (3.0%) were African-American, 47 17 
(78.3%) were Caucasian, 10 (16.6%) were Hispanic, and one (1.6%) was Native American. All 18 
60 had experienced at least one mTBI, with the most recent TBI occurring a mean of 8.5 months 19 
(SD= 6.58 months, range= 3-39 months) prior to the baseline assessments. Cause of concussion 20 
included improvised explosive device (IED) blast (85.3%), rocket propelled grenades (3.0%), 21 
and mortar attacks (1.7%). The remaining 10% were uncategorized blasts. Slightly more than 22 
one-quarter of the participants self-reported additional concussions (M = 2.1, SD=.95, range=1-23 
12 
 
4) prior to the most recent blast injury.  The symptoms of the Group A cohort were characterized 1 
as mild on the RPQ symptomatic, with 7 of the 16 items endorsed in the range of 2 (a mild 2 
problem) and only one item (forgetfulness) in the range of 3 (a moderate problem).13 3 
Importantly, the three vision-related items, blurred vision, light sensitivity and double vision, on 4 
the RPQ were reported as either never having been a problem or no longer a problem, so no 5 
subjects reported active difficulty with vision. Twenty six healthy undergraduate, graduate or 6 
post-graduate trainees served as controls. None had sustained a mild TBI and all were 7 
asymptomatic.   8 
 9 
Saccades. Saccadic data from the horizontal and vertical target displacement tasks for subjects 10 
with symptomatic mTBI and controls were compared using 11 measures (see Table 1). Data 11 
from horizontal and vertical direction eye movements were analyzed for the horizontal and 12 
vertical target displacement tasks, respectively.  13 
 14 
*** Insert Table 1 Here *** 15 
 16 
Main Sequence Data for Saccadic Data. For each subject, peak velocity, peak 17 
acceleration, duration and saccadic amplitude data for all saccades were fit to the models for both 18 
horizontal and vertical displacement tasks. All fits were performed using the nonlinear curve 19 
fitting toolbox in MATLAB (Mathworks, MA). As is standard in the eye-tracking literature, 20 
exponential models were used for peak velocity and peak acceleration, while a power function 21 
model was used for duration.
28
 This process generated the parameters asymptotic velocity, 22 
asymptotic acceleration, exponential rise (for both velocity and acceleration), predicted duration   23 
13 
 
of a 1 degree saccade, and the percentage rate of change for predicted duration of a 1-degree 1 
saccade, giving rise to 6 measures. The root-mean-square error for each of the three model fits 2 
was checked for goodness of fit. The RMSE was also compared between groups to see if one 3 
group had more variance than the other, adding 3 more measures. After curves were fit for each 4 
subject, the predicted peak velocity, peak acceleration, and duration from the models for 1 5 
degree and 5 degree saccades were compared between symptomatic mTBI subjects and controls, 6 
providing 5 more measures. Figure 1 shows typical model fits for peak velocity, acceleration and 7 
duration. 8 
 9 
*** Insert Figure 1 Here *** 10 
 11 
Horizontal and Vertical Tracking Step Data. Of the 11 accuracy variables and the 14 12 
main sequence variables, 11 (5 accuracy and 6 main sequence) variables show significant 13 
differences between Groups A and B for both horizontal and vertical displacement tasks (p-value 14 
< .05). Results are summarized in Tables 2 and 3. 15 
 16 
*** Insert Tables 2 and 3 Here *** 17 
 18 
Smooth Pursuit. Data for horizontal and vertical smooth pursuit tasks were analyzed using 7 19 
measures (see Table 4). Data from eye movement in the horizontal and vertical directions were 20 
analyzed for the horizontal and vertical smooth pursuit tasks, respectively.  21 
 22 
*** Insert Table 4 Here *** 23 
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 1 
Horizontal and Vertical Ramp Data. Of these seven variables, only two showed 2 
significant differences between Groups A and B (p-value < .05).  No support was present in any 3 
of the cases for an assumption that data came from a normally distributed population even after 4 
log transformation.  Accordingly, in our analysis, the non-parametric Mann-Whitney U test for 5 
comparing independent samples was used.   6 
 7 
*** Insert Table 5 Here *** 8 
 9 
Fixation. Fixation data for all subjects came from fixations between saccades from the horizontal 10 
target displacement task. To minimize the potential effect due to target eccentricity, only  11 
fixations around the origin were included in the analysis. Fixation was compared between groups 12 
using 10 measures (see Table 6). 13 
 14 
*** Insert Table 6 Here *** 15 
 16 
 No differences were found using either parametric or non-parametric methods. Additionally, no 17 
results were found running parametric tests on log transformed data, which was closer to 18 
normally distributed. 19 
 20 
Discussion 21 
Diagnosing and monitoring recovery after mTBI, using either subjective or objective parameters, 22 
is challenging.  Importantly, the study revealed significant differences in a number of eye 23 
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tracking components, both for tasks involving a step displacement of the target and for smooth 1 
pursuit tasks. Uncovering these differences represents a vital initial step towards development of 2 
objective tests which can discriminate between individuals with symptomatic mTBI and controls. 3 
This investigation represents the first examination of the utility of eye tracking to identify 4 
objective findings in individuals with subjective symptoms after mTBI using a non-mTBI control 5 
group for comparison. Given the challenges of both diagnosing and monitoring recovery after 6 
mTBI, using either subjective or objective parameters, this study represents a significant step 7 
forward.  8 
Importantly, we found significant differences in two of the three eye tracking parameters 9 
studied: saccades and SPEM. Robust differences were found between responses of subjects with 10 
symptomatic mTBI and controls to horizontal and vertical stepwise target displacement tasks, 11 
with subjects with symptomatic mTBI having statistically larger position errors, smaller saccadic 12 
amplitudes, smaller predicted peak velocities, smaller peak accelerations, and longer durations. 13 
Subjects with symptomatic mTBI were also more likely to respond to step changes in target 14 
position with smaller primary saccades compared to controls. In general, symptomatic mTBI 15 
tracked the stepwise moving targets less accurately, revealing possible brain dysfunction. This 16 
investigation represents the first examination of the utility of eye tracking using a non-mTBI 17 
control group as a means to identify objective findings in individuals with subjective symptoms 18 
after mTBI.   Differences in responses to smooth pursuit tasks were also found between subject 19 
groups, although not as robust as the differences between mTBI subjects and controls. Here, the 20 
saccadic amplitudes were significantly different.  The amplitudes were larger for subjects with 21 
symptomatic mTBI for the horizontal smooth pursuit task.  In comparison to controls, pursuit 22 
gain was lower among subjects with symptomatic mTBI. Surprisingly, in contrast to a number of 23 
16 
 
other neurological disorders, no differences were found between groups for fixation measures.  1 
Further investigation into the specificity and sensitivity of these measures in light of the often 2 
complex polytraumatic nature of individuals with either combat or civilian-related injury (e.g., 3 
presence of acute or chronic conditions, anxiety disorders, depression, pain and substance abuse) 4 
is warranted. This represents an important initial step in the understanding of the role of both eye 5 
movement abnormalities and computerized eye tracking in the diagnosis and monitoring of 6 
symptomatic mTBI. Specific linkages between symptoms, eye tracking abnormalities, and 7 
neuropathology (as revealed by neuroimaging) may be an important subsequent step. 8 
The wide array of abnormalities uniquely found in the mTBI cohort may have 9 
contributed to their diverse complaints, including headache, blurred/double vision, dizziness, 10 
clumsiness, reading difficulties, and driving problems. Future studies correlating the magnitude 11 
and type of the range of eye movement errors with ecologic complaints would be a fruitful area 12 
of further investigation. These analyses could also assist in the development of both predictive 13 
models for symptom development and recovery, and in the development of effective treatments 14 
for specific symptom-eye tracking abnormality associations.  15 
This study utilized standard protocols to define exposure to a PCE, to be symptomatic for 16 
PCS, and for eye tracking, which allowed us to remove much of the subjectively commonly 17 
encountered in mTBI research. However there were some limitations to the research design that 18 
may limit its generalizability. These include; gender, restricted age, etiology of mTBI, chronicity 19 
of mTBI and symptoms, variability in symptom treatments, and co-morbid conditions. These 20 
restrictions may be less significant, in particular to the Departments of Defense and Veterans 21 
Affairs systems, since the bulk of individuals with mTBI seen in these systems tend to be 22 
younger males with complex military theatre polytrauma injuries.
29
 Future studies will focus on 23 
17 
 
larger samples of individuals that include cohorts with more discrete causes of symptom 1 
complex (e.g., isolated mTBI, isolated stress disorders, isolated pain complaints), in an attempt 2 
to identify unique patterns of eye movement abnormalities based on etiology of symptoms. 3 
Additionally, analyses of the impact of symptom patterns on eye movement seen, as well as the 4 
association between differential patterns of eye movement abnormalities with symptom 5 
presentations, can be performed with larger subject samples. Lastly, temporal associations 6 
between injury, symptom presentation, and eye movement abnormalities may be an important 7 
key to use of eye tracking to monitor recovery after mTBI. 8 
9 
18 
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Table 1 9 
Measures for Comparing Saccadic Data 10 
 11 
Number of Primary Saccades: the number of times the subject made at least one 
saccadic movement following a target movement (if target moved again before the 
subject then no primary saccade was recorded) 
Number of correcting saccades: the total number of saccades excluding the primary 
saccades following the target movements 
Average Latency: the mean reaction time to each target movement  
Primary Position Error: the absolute value of the difference between the target 
displacement and the amplitude of the primary saccades.  Three sub-measures of primary 
position error were calculated:  
 Mean of the Normalized Position Error. the mean of the absolute value of the 
ratio between the position error and the target amplitude. Normalization attempts to 
account for the dependency of the amplitude of the position error on the amplitude 
of the target displacement.  
 Standard Deviation of the Ratios of the Position Error and the Target 
Displacement. 
 Mean of the Absolute Value of the Non-normalized Position Errors. 
Final Position Error: the absolute value of the difference between the target 
displacement and the position of the eye before the next target movement. The same three 
sub-measures for primary position error were calculated for final position error. 
Mean of the Absolute Value of the Normalized Primary Saccadic Amplitude: the 
mean of the absolute value of the ratio between the primary saccadic amplitude and the 
target amplitude for all saccades per individual. Here, normalization attempts to account 
for the dependency of the amplitude of the primary saccades on the amplitude of the 
target displacement. 
Mean Q-Ratio: the mean of the ratio between peak velocity and saccadic amplitude over 
all saccades per individual. 
 12 
  13 
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Table 2 6 
Horizontal Displacement Task 7 
 8 
 
HORIZONTAL 
TRACKING 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Type of test* 
Mean of normalized 
primary position error 
.4255 .2043 .000 nonparametric 
SD of normalized 
primary position error 
.6993 .3502 .000 nonparametric 
Mean of normalized 
final position error 
.2993 .1346 .016 nonparametric 
Mean of non-
normalized primary 
position error 
4.7572 2.3803 .000 nonparametric 
Number of primary 
saccades 
20.64 24.92 .000 nonparametric 
Predicted Velocity, 1-
deg amp 
55.4612 59.4678 .008 parametric 
Predicted Velocity, 5-
deg amp 
219.71 235.51 .001 parametric 
Predicted Acceleration, 
1-deg amp 
3464.97 3712.18 .026 parametric 
Predicted Acceleration, 
5-deg amp 
12495.4 13530.74 .003 parametric 
Predicted Duration, 1-
deg amp 
36.60 34.71 .000 nonparametric 
Predicted Duration, 5-
deg amp 
61.62 56.93 .000 nonparametric 
CAPTION:  55 Group A and 26 Group B had complete results for all of the horizontal target displacement 9 
tasks 10 
 11 
*In all cases in this table, the employment of nonparametric rather than parametric tests did not affect whether the 12 
difference between groups was significant. 13 
  14 
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Table 3 6 
Vertical Displacement Task 7 
 8 
VERTICAL 
TRACKING 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Type of test* 
Mean of normalized 
primary position error 
.4093 .2523 .002 parametric 
SD of normalized 
primary position error 
.5737 .3416 .011 nonparametric 
Mean of normalized 
final position error 
.3184 .1817 .004 parametric 
Mean of non-
normalized primary 
position error 
3.0513 1.9616 .054* parametric 
Number of primary 
saccades 
22.74 24.72 .000 nonparametric 
Predicted Velocity, 1-
deg amp 
52.61 58.94 .000 parametric 
Predicted Velocity, 5-
deg amp 
213.5 229.9 .001 parametric 
Predicted Acceleration, 
1-deg amp 
3121.93 3508.92 .000 parametric 
Predicted Acceleration, 
5-deg amp 
11714.6 12906.8 .000 nonparametric 
Predicted Duration, 1-
deg amp 
39.36 35.97 .000 parametric 
Predicted Duration, 5-
deg amp 
66.67 59.78 .000 nonparametric 
CAPTION: 47 Group A and 26 Group B had complete results for all of the vertical target displacement 9 
tasks. 10 
 11 
*In all cases in this table, the employment of nonparametric rather than parametric tests did not affect whether the 12 
difference between groups was significant. 13 
  14 
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Table 4 7 
Measures for Comparing Smooth Pursuit Data 8 
 9 
Number of Saccades: the total number of saccades during a smooth pursuit task 
Mean Gain: the mean of the ratios of eye velocity and target velocity between saccades 
Minimum Gain: the minimum of the ratios of eye velocity and target velocity between 
saccades 
Maximum Gain: the maximum of the ratios of eye velocity and target velocity between 
saccades 
Mean Absolute Saccadic Amplitude: the mean of the absolute value of saccadic 
amplitude calculated across all saccades during the tasks 
Mean Duration: the mean length of time eyes are smoothly pursuing the target between 
saccades 
Mean Absolute Normalized Saccadic Amplitude: the mean of the absolute value of the 
ratio of saccadic amplitude and target velocity. Normalization by target velocity attempts 
to account for dependency of saccadic amplitude on the velocity of the target. 
 10 
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Table 5 7 
Smooth Pursuit Ramp Data 8 
 9 
HORIZONTAL 
RAMP 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Min Gain .0804 .1088 .000 
Mean normalized 
amplitude 
.2208 .1561 .017 
 10 
VERTICAL RAMP Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Min Gain .0761 .1013 .011 
Mean normalized 
amplitude 
.2253 .2933 .016 
CAPTION: 55 Group A and 24 Group B had complete results for all of the horizontal smooth 11 
pursuit tasks; 49 Group A and 23 Group B had complete results for all of the vertical smooth pursuit 12 
tasks 13 
  14 
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Figure 1 1 
Sample Model Fits 2 
 3 
.. 4 
Caption: Example model fits for an individual subject.  Peak Velocity, Acceleration and Duration versus Saccadic 5 
Amplitude (Top, Middle and Bottom, respectively). The blue dots represent absolute values of data recorded from a 6 
horizontal step displacement task. The red lines are the corresponding model fits. 7 
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Number of Primary Saccades: the number of times the subject made at least one 
saccadic movement following a target movement (if target moved again before the 
subject then no primary saccade was recorded) 
Number of correcting saccades: the total number of saccades excluding the primary 
saccades following the target movements 
Average Latency: the mean reaction time to each target movement  
Primary Position Error: the absolute value of the difference between the target 
displacement and the amplitude of the primary saccades.  Three sub-measures of primary 
position error were calculated:  
 Mean of the Normalized Position Error. the mean of the absolute value of the 
ratio between the position error and the target amplitude. Normalization attempts to 
account for the dependency of the amplitude of the position error on the amplitude 
of the target displacement.  
 Standard Deviation of the Ratios of the Position Error and the Target 
Displacement. 
 Mean of the Absolute Value of the Non-normalized Position Errors. 
Final Position Error: the absolute value of the difference between the target 
displacement and the position of the eye before the next target movement. The same three 
sub-measures for primary position error were calculated for final position error. 
Mean of the Absolute Value of the Normalized Primary Saccadic Amplitude: the 
mean of the absolute value of the ratio between the primary saccadic amplitude and the 
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for the dependency of the amplitude of the primary saccades on the amplitude of the 
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all saccades per individual. 
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 Table 2 
Horizontal Displacement Task 
 
 
HORIZONTAL 
TRACKING 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Type of test* 
Mean of normalized 
primary position error 
.4255 .2043 .000 nonparametric 
Std dev of normalized 
primary position error 
.6993 .3502 .000 nonparametric 
Mean of normalized 
final position error 
.2993 .1346 .016 nonparametric 
Mean of non-
normalized primary 
position error 
4.7572 2.3803 .000 nonparametric 
Number of primary 
saccades 
20.64 24.92 .000 nonparametric 
Predicted Velocity, 1-
deg amp 
55.4612 59.4678 .008 parametric 
Predicted Velocity, 5-
deg amp 
5.3852 5.4592 .001 parametric 
Predicted Acceleration, 
1-deg amp 
3464.97 3712.18 .026 parametric 
Predicted Acceleration, 
5-deg amp 
12495.4 13530.74 .003 parametric 
Predicted Duration, 1-
deg amp 
36.60 34.71 .000 nonparametric 
Predicted Duration, 5-
deg amp 
61.62 56.93 .000 nonparametric 
CAPTION:  55 Group A and 26 Group B had complete results for all of the horizontal target displacement 
tasks 
 
*In all cases in this table, the employment of nonparametric rather than parametric tests did not affect whether the 
difference between groups was significant. 
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Table 3 
Vertical Displacement Task 
 
VERTICAL 
TRACKING 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Type of test* 
Mean of normalized 
primary position error 
.4093 .2523 .002 parametric 
Std dev of normalized 
primary position error 
.5737 .3416 .011 nonparametric 
Mean of normalized 
final position error 
.3184 .1817 .004 parametric 
Mean of non-
normalized primary 
position error 
3.0513 1.9616 .054* parametric 
Number of primary 
saccades 
22.74 24.72 .000 nonparametric 
Predicted Velocity, 1-
deg amp 
52.61 58.94 .000 parametric 
Predicted Velocity, 5-
deg amp 
213.5 229.9 .001 parametric 
Predicted Acceleration, 
1-deg amp 
3121.93 3508.92 .000 parametric 
Predicted Acceleration, 
5-deg amp 
11714.6 12906.8 .000 nonparametric 
Predicted Duration, 1-
deg amp 
39.36 35.97 .000 parametric 
Predicted Duration, 5-
deg amp 
66.67 59.78 .000 nonparametric 
CAPTION: 47 Group A and 26 Group B had complete results for all of the vertical target displacement 
tasks. 
 
*In all cases in this table, the employment of nonparametric rather than parametric tests did not affect whether the 
difference between groups was significant. 
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Table 4 
Measures for Comparing Smooth Pursuit Data 
 
Number of Saccades: the total number of saccades during a smooth pursuit task 
Mean Gain: the mean of the ratios of eye velocity and target velocity between saccades 
Minimum Gain: the minimum of the ratios of eye velocity and target velocity between 
saccades 
Maximum Gain: the maximum of the ratios of eye velocity and target velocity between 
saccades 
Mean Absolute Saccadic Amplitude: the mean of the absolute value of saccadic 
amplitude calculated across all saccades during the tasks 
Mean Duration: the mean length of time eyes are smoothly pursuing the target between 
saccades 
Mean Absolute Normalized Saccadic Amplitude: the mean of the absolute value of the 
ratio of saccadic amplitude and target velocity. Normalization by target velocity attempts 
to account for dependency of saccadic amplitude on the velocity of the target. 
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Table 5 
Smooth Pursuit Ramp Data 
 
HORIZONTAL 
RAMP 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Min Gain .0804 .1088 .000 
Mean normalized 
amplitude 
.2208 .1561 .017 
 
VERTICAL RAMP Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Min Gain .0761 .1013 .011 
Mean normalized 
amplitude 
.2253 .2933 .016 
CAPTION: 55 Group A and 24 Group B had complete results for all of the horizontal smooth 
pursuit tasks; 49 Group A and 23 Group B had complete results for all of the vertical smooth pursuit 
tasks 
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Figure 1 
Sample Model Fits 
 
 
Caption: Example model fits for an individual subject.  Peak Velocity, Acceleration and Duration versus Saccadic 
Amplitude (Top, Middle and Bottom, respectively). The blue dots represent absolute values of data recorded from a 
horizontal step displacement task. The red lines are the corresponding model fit. 
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Abstract 1 
Objective measures to diagnose and to monitor improvement of symptoms following mild 2 
traumatic brain injury (mTBI) are lacking. Computerized eye tracking has been advocated as a 3 
rapid, user friendly and field ready technique to meet this need. Eye tracking data collected via a 4 
head mounted, video-based binocular eye tracker was used to examine saccades, fixations and 5 
smooth pursuit movement in 60  military Service Members  with post concussive syndrome 6 
(PCS) and 26  asymptomatic control subjects in an effort to determine if eye movement 7 
differences could be found and quantified. The diagnosis of mTBI was confirmed by the study 8 
physiatrist’s history, physical examination, and a review of any medical records. Results 9 
demonstrated that subjects with symptomatic mTBI had statistically larger position errors, 10 
smaller saccadic amplitudes, smaller predicted peak velocities, smaller peak accelerations, and 11 
longer durations. Subjects with symptomatic mTBI were also less likely to follow a target 12 
movement (less primary saccades). In general, symptomatic mTBI tracked the stepwise moving 13 
targets less accurately, revealing possible brain dysfunction. A reliable, standardized protocol 14 
that appears to differentiate mTBI from normals was developed for use in future research. This 15 
investigation represents a step toward objective identification of those with PCS. Future studies 16 
focused on increasing the specificity of eye movement differences in those with PCS are needed. 17 
 18 
Key words: mild traumatic brain injury, post-concussion syndrome, eye tracking, saccades, 19 
fixations, smooth pursuit 20 
 21 
  22 
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Introduction 1 
As a result of injuries to both military servicemembers in combat and athletes in contact 2 
sports, there has been heightened focus on metrics to diagnose and monitor recovery after mild 3 
traumatic brain injury (mTBI) and related sequelae.
1,2
 A significant limiting factor in the 4 
diagnostic approach to mTBI has been the dependence on self-report of injury and symptoms, 5 
resulting in a provisional syndromic-based diagnosis, post-concussion syndrome (PCS). 6 
Increasingly there has been recognition that an mTBI is more accurately termed as a “potentially 7 
concussive event” (PCE), rather than a syndrome.3-5 If specific criteria (e.g., alteration or loss of 8 
consciousness with associated memory loss/amnesia surrounding the event) are confirmed, then 9 
the diagnosis of mTBI may be made. If these criteria are not met, then the PCE cannot be labeled 10 
as an mTBI, but may still manifest with symptoms related to secondary physical injury (e.g., 11 
neck or skull-based musculature and other soft-tissue) and psychological trauma (e.g., acute 12 
stress reaction). It is more proper to apply the “syndrome” label only after the mTBI has been 13 
confirmed and has manifest in a symptom complex that has persisted for more than three months 14 
after injury.
6
 Importantly, even in the case of a confirmed mTBI, the effects of other physical and 15 
psychological conditions often contribute to the symptoms and syndrome.
5 16 
The limitations of the current self-reported, subjective accounting of traumatic events, 17 
symptoms, and improvements are manifold. Without objective documentation of the PCE, such 18 
as pre-event neuropsychological screening, event videotaping, or data from accelerometers, these 19 
potential confounders include: altered or imprecise recall of event duration, severity, and date of 20 
occurrence, potentially inaccurate estimation of pre-event functioning, impact of acute stress 21 
response, and motivation (positive or negative) to accurately report symptoms. These factors are 22 
further influenced by the elapsed time between the event and medical assessment of the subject. 23 
4 
 
This is important at both the proximal (e.g., secondary factors surrounding the event or trauma 1 
that resulted in the PCE, acute recognition of PCE and/or mTBI, acute management of 2 
PCE/mTBI) and distal (e.g., increasing inaccuracy of precise recall weeks, months, or even years 3 
post-event, subsequent symptoms that arise after PCE, recognition, acknowledgement, and 4 
eventual assessment of the PCE/mTBI, ongoing management of the PCE and subsequent 5 
symptoms) ends of the encounter with the medical professional.  6 
 In addition to the use of self-reported injury events and post-injury symptoms, cognitive 7 
screens and more comprehensive neuropsychological testing have predominantly been utilized to 8 
diagnose and monitor recovery after mTBI. While this approach is well validated and has proven 9 
clinically useful, it also has a number of inherent limitations. Principal criticisms of the testing 10 
approach include the subjectivity of self-report, patient fatigue and motivation factors, practice 11 
effects, and influence of co-morbid conditions (e.g., pain, anxiety, depression, substance abuse). 12 
Additionally, testing batteries often vary in composition based on the practice patterns of 13 
individual clinicians, limiting the ability to compare across time and testing centers, with 14 
subsequent limitations on meaningful meta-analysis. There is no universally accepted 15 
neuropsychological testing battery after PCE. 16 
 There is increasing enthusiasm to rely on objective measures to determine the 17 
relationship of both a PCE to an mTBI and an mTBI to persistent symptoms. There are few well-18 
designed, large scale studies examining early brain changes following mTBI using diagnostic 19 
devices, although many devices and techniques for objectively measuring the brain have been 20 
proposed and examined.  Some involve measures of brain activity (e.g., electroencephalography 21 
[EEG], evoked responses)
7-9
, structure (diffusion tensor imaging [DTI], high density fiber 22 
tracking [HDFT])
10-12
,  hemodynamics (e.g., near-infrared spectroscopy [NIRS], transcranial 23 
5 
 
Doppler ultrasound [TCD])
13-15
, and functional testing (e.g., computerized posturography, 1 
computerized tests of cognition and executive function)
16-18
. Other efforts have focused on 2 
devices that attempt to measure intracranial pathology, such as intracranial hypertension via 3 
observation of extracranial phenomena (e.g., optic nerve sheath diameter [ONSD] or otoacoustic 4 
emissions).
19
 Despite the vigor of studying the utility and validity of these diagnostic approaches, 5 
none have achieved a level of efficacy to be considered as the “gold standard,” and 6 
multidimensional approaches using diagnostic algorithms have not been developed. 7 
One method for the objective assessment of the brain after PCE and mTBI that has shown 8 
promise as a user friendly, low cost, non-invasive, definitive approach is eye tracking. Eye 9 
tracking has been advocated as a rapid, convenient, and portable (i.e., field ready) method of 10 
evaluation However, specific research on its specificity and sensitivity is sparse in this 11 
population. Although specific values are not universally presented,
20
 one study suggested that the 12 
sensitivity and specificity of eye tracking paradigms reaches 100% when differentiating controls 13 
from mTBI, or even differentiating PCS from non-PCS in a suspected mTBI population.
21
  These 14 
results have not been replicated. Previous reports have shown the primary oculomotor deficits in 15 
mTBI to be difficulty reading (oculomotor specific), vergence, accommodation, and saccadic 16 
gain abnormalities.
22
 Eye tracking assessment typically involves the examination of saccades, 17 
fixation, and smooth pursuit eye movements (SPEM). Saccades (rapid, accurate, ballistic shifting 18 
of gaze to a new area of interest) are studied because they require the complex coordination and 19 
timing of neural circuitry in numerous different brain areas, including primarily the frontal lobe, 20 
basal ganglia, superior colliculus, and the cerebellum; and would therefore be likely to be 21 
sensitive indicators of injury to one of these areas.
23
 Further, the various parameters (e.g. 22 
direction, gain, velocity, trajectory, etc.) of saccades are “programmed” independent of each 23 
6 
 
other, generally free of cognitive influence, and can be studied both separately and in 1 
combination.
23
  Up to the present, fixation (maintaining an image of interest on the fovea) data 2 
have not been well studied in TBI patients, largely due to the technical challenges in measuring 3 
fixations, and the prevailing belief that the fixations themselves are “silent,’ offering no 4 
meaningful data. Fortunately, the technological limitations have been largely overcome with the 5 
latest generation of measurement tools and applied analyses. The “silent” nature of fixation 6 
deficits seems likely more an under appreciation of the linkage between subtle (often difficult to 7 
measure) visual processing deficits and a range of functional tasks (e.g., reading, driving) or 8 
somatic complaints (e.g., headache, dizziness). SPEM have been examined in this population, 9 
and while typically felt to be an important component of the visual complaints that are frequently 10 
voiced by individuals with persistent symptoms, studying this association has been met with 11 
equivocal results.
24
 Given the importance of vision and the visual system to humans, the 12 
frequency of post-concussive symptoms that may be attributed to the visual system, suggestions 13 
of linkages in prior research and  advances in eye tracking technology and analyses, further 14 
research into the use of techniques to study eye movements after mTBI is warranted. 15 
This study examined the utility of a standardized eye tracking protocol to differentiate 16 
individuals with self-reported, chronic effects of mTBI from symptom-free individuals without a 17 
reported history of mTBI. For this investigation, we hypothesized that there would be significant 18 
injury-related differences in saccades, fixational, and SPEM eye movements between 19 
symptomatic individuals and controls. If present, these differential findings could be used to 20 
differentiate between individuals who have sustained an mTBI versus those who have not. 21 
Additionally, it is the first step in a potentially differentiate individuals with focused symptoms 22 
related to mTBI and those more likely due to other causes or co-morbid conditions. 23 
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 1 
Methods 2 
This study received all appropriate institutional review board and governmental approvals.  For 3 
this study, 60 subjects with PCS (Group A), who were part of a larger Department of Defense 4 
clinical trial, were recruited primarily from United States military bases and 26 normal controls 5 
(Group B) were recruited from an academic medical center. All subjects were evaluated by a TBI 6 
research team, led by a physiatrist (DXC), and a positive or negative history of TBI was 7 
ascertained. The diagnosis of TBI was confirmed by the study physiatrist’s history, physical 8 
examination, and a review of any medical records for the subjects. Post-concussive symptoms, if 9 
present, were documented using the Rivermead Postconcussive Symptom Questionnaire 10 
(RPQ).
27
The RPQ is a widely used Likert-type symptom inventory consisting of 16 items [rated 11 
from 0 (never a problem) to 4 (severe problem)], designed to evaluate the somatic, cognitive and 12 
emotional functioning of individuals who have sustained a concussion. Whether part of the RPQ 13 
administration (subjects with mTBI) or via direct questioning, all subjects were questioned as to 14 
whether they had any subjective visual complaints, such as blurred vision, double vision, or 15 
floaters.  16 
A head mounted video-based binocular eye tracker (Eyelink II, SR Research, Kanata, 17 
Ontario, CAN) was used to record horizontal and vertical binocular gaze data at 500 samples per 18 
second. To minimize head movement, the subject’s head was supported by an adjustable chin 19 
rest cup.  Stimuli covering ±20° horizontally and ±13° vertically were presented at 120 Hz on a 20 
24-in LCD monitor placed 75 cm from the subject’s eyes in a darkened room. The height of the 21 
monitor display was adjusted so that the center of the screen corresponded to the center of the 22 
pupillary plane. Calibration and validation of the eye tracker was performed at three points along 23 
8 
 
each cardinal axis immediately before recording commenced.  The target stimulus was a white 1 
annulus, sized to occupy 0.25° of visual angle, with a high-contrast center point of 0.1° presented 2 
on a black background. Stimuli consisted of random, unpredictable step target movements and 3 
smooth pursuit paradigms in both the horizontal and vertical directions.  Subjects were allowed 4 
to close their eyes and rest between each recording to prevent fatigue.  5 
Eye position data were analyzed through a multi-step process involving initial visual 6 
inspection of the eye position recordings, followed by the use of specialized automated analysis 7 
algorithms, and lastly visual confirmation of the automated measures.  In all trials, the horizontal 8 
and vertical positions of each eye were analyzed. During automated analysis, the criteria for 9 
detecting a saccade required that the amplitude of the movement was greater than ±0.1°, the 10 
duration of the saccade fell within a predetermined minimum and maximum time limit, and that 11 
the calculated velocity and acceleration values (based on a two-point central difference method) 12 
were greater than ±20°/s and ±400°/s
2
, respectively, but also did not exceed a set of 13 
predetermined upper limits (in absolute value) for both velocity and acceleration. Responses that 14 
failed to meet the detection criteria for a saccade could then be considered as smooth pursuit, 15 
fixation when the eye is relatively stable, or artifact.  If the response was considered artifact, the 16 
analysis program would identify and mark the data for further inspection.  For any saccadic eye 17 
movement, the time, location, and amplitude of the saccade, as well as, its direction, duration, 18 
peak velocity, and peak acceleration and deceleration reached during the movement were 19 
determined and stored in a measurement summary file for later statistical analysis. For trials 20 
involving step changes in target position, the response latency (the time between the onset of 21 
target movement and response) were measured and recorded.   The saccadic gain was calculated 22 
as the ratio between the amplitude of the primary saccade (first saccade after target movement) 23 
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and the displaced target amplitude (total change in target position).  As a measure of positioning 1 
accuracy, the number and amplitudes of any additional corrective saccades that occurred after the 2 
primary saccade were recorded, as well as the final position error between the target and the eye.  3 
The inter-saccadic interval (time between saccades) defined a period the affixation period, or 4 
potentially, the duration of smooth pursuit.  5 
Fixation is characterized by relatively stable eye position with movement that has low 6 
velocity, low acceleration and no directional trend.  During fixation, the length of time was 7 
recorded and several measures of stability were performed.  Stability measures included 8 
computation of the position variance, computation of the root mean square (RMS) of eye 9 
velocity, and determination of the mean and absolute mean velocity of the eyes during fixation.  10 
As an additional measure of stability, bivariate contour elliptical analysis (BCEA) was used to 11 
define the orientation, semi-major and semi-minor dimensions, and area (degs
2
) of an elliptical 12 
contour which captured 90 percent of the fixation data during fixation on the zero degree, center 13 
target position.  These same data were also applied to a discrete Fourier transform (DFT) which 14 
determiner the frequency content or spectrum during fixation.   15 
Smooth pursuit occurs when the velocity of the eye closely matches the direction and 16 
velocity of the target.  Velocity mismatches between eye and target result in position errors, 17 
which are corrected by saccadic intrusions.  During pursuit, the velocity of the eye is greater 18 
compared to fixation velocity, while the pursuit acceleration is far less than what occurs during a 19 
saccade.  During periods of smooth pursuit, the number of saccades, saccadic amplitude, and 20 
pursuit gain were determined.  Pursuit gain, defined as the ratio between the weighted mean eye 21 
velocity and target velocity, was determined without inclusion of any corrective saccades.  22 
 23 
10 
 
Results 1 
Statistical Analyses. All statistical analyses were conducted using SPSS Statistics version 21.0 2 
(IBM SPSS). Data were assessed for normality using the Shapiro-Wilk test. Parameters that were 3 
not normally distributed (i.e., Shapiro-Wilk P value>.05) were then log-transformed and 4 
rechecked for normality.  Independent-sample, unpaired, 2-tailed t-tests (on either original 5 
variables or log transformed variables) were conducted to assess for differences between Groups 6 
A and B. The Levene test for the equality of variances was calculated, and if the significance was 7 
found to be less than .05, equal variances were not assumed.  In many cases, the data did not give 8 
any indication that the populations were normal or even log-normal (predominantly because of 9 
outliers).  For these variables, we used the non-parametric Mann-Whitney U test for comparing 10 
independent samples.  For each task, data from the right eye were analyzed as no within group 11 
left-right eye differences were noted in the cohort. Given the challenges in normalizing all data, 12 
the number of subject measurement points varied from task to task. 13 
 14 
Descriptive Data. There were 60 research subjects with symptomatic mTBI (Group A) and 26 15 
control subjects without a history of TBI or symptoms (Group B). All Group A subjects were 16 
male and had a mean age of 23.2 years (SD=2.95). Two (3.0%) were African-American, 47 17 
(78.3%) were Caucasian, 10 (16.6%) were Hispanic, and one (1.6%) was Native American. All 18 
60 had experienced at least one mTBI, with the most recent TBI occurring a mean of 8.5 months 19 
(SD= 6.58 months, range= 3-39 months) prior to the baseline assessments. Cause of concussion 20 
included improvised explosive device (IED) blast (85.3%), rocket propelled grenades (3.0%), 21 
and mortar attacks (1.7%). The remaining 10% were uncategorized blasts. Slightly more than 22 
one-quarter of the participants self-reported additional concussions (M = 2.1, SD=.95, range=1-23 
11 
 
4) prior to the most recent blast injury.  The symptoms of the Group A cohort were characterized 1 
as mild on the RPQ symptomatic, with 7 of the 16 items endorsed in the range of 2 (a mild 2 
problem) and only one item (forgetfulness) in the range of 3 (a moderate problem).13 3 
Importantly, the three vision-related items, blurred vision, light sensitivity and double vision, on 4 
the RPQ were reported as either never having been a problem or no longer a problem, so no 5 
subjects reported active difficulty with vision. Twenty six healthy undergraduate, graduate or 6 
post-graduate trainees served as controls. None had sustained a mild TBI and all were 7 
asymptomatic.   8 
 9 
Saccades. Saccadic data from the horizontal and vertical target displacement tasks for subjects 10 
with symptomatic mTBI and controls were compared using 11 measures (see Table 1). Data 11 
from horizontal and vertical direction eye movements were analyzed for the horizontal and 12 
vertical target displacement tasks, respectively.  13 
 14 
*** Insert Table 1 Here *** 15 
 16 
Main Sequence Data for Saccadic Data. For each subject, peak velocity, peak 17 
acceleration, duration and saccadic amplitude data for all saccades were fit to the models for both 18 
horizontal and vertical displacement tasks. All fits were performed using the nonlinear curve 19 
fitting toolbox in MATLAB (Mathworks, MA). As is standard in the eye-tracking literature, 20 
exponential models were used for peak velocity and peak acceleration, while a power function 21 
model was used for duration.
28
 This process generated the parameters asymptotic velocity, 22 
asymptotic acceleration, exponential rise (for both velocity and acceleration), predicted duration   23 
12 
 
of a 1 degree saccade, and the percentage rate of change for predicted duration of a 1-degree 1 
saccade, giving rise to 6 measures. The root-mean-square error for each of the three model fits 2 
was checked for goodness of fit. The RMSE was also compared between groups to see if one 3 
group had more variance than the other, adding 3 more measures. After curves were fit for each 4 
subject, the predicted peak velocity, peak acceleration, and duration from the models for 1 5 
degree and 5 degree saccades were compared between symptomatic mTBI subjects and controls, 6 
providing 5 more measures. Figure 1 shows typical model fits for peak velocity, acceleration and 7 
duration. 8 
 9 
*** Insert Figure 1 Here *** 10 
 11 
Horizontal and Vertical Tracking Step Data. Of the 11 accuracy variables and the 14 12 
main sequence variables, 11 (5 accuracy and 6 main sequence) variables show significant 13 
differences between Groups A and B for both horizontal and vertical displacement tasks (p-value 14 
< .05). Results are summarized in Tables 2 and 3. 15 
 16 
*** Insert Tables 2 and 3 Here *** 17 
 18 
Smooth Pursuit. Data for horizontal and vertical smooth pursuit tasks were analyzed using 7 19 
measures (see Table 4). Data from eye movement in the horizontal and vertical directions were 20 
analyzed for the horizontal and vertical smooth pursuit tasks, respectively.  21 
 22 
*** Insert Table 4 Here *** 23 
13 
 
 1 
Horizontal and Vertical Ramp Data. Of these seven variables, only two showed 2 
significant differences between Groups A and B (p-value < .05).  No support was present in any 3 
of the cases for an assumption that data came from a normally distributed population even after 4 
log transformation.  Accordingly, in our analysis, the non-parametric Mann-Whitney U test for 5 
comparing independent samples was used.   6 
 7 
*** Insert Table 5 Here *** 8 
 9 
Fixation. Fixation data for all subjects came from fixations between saccades from the horizontal 10 
target displacement task. To minimize the potential effect due to target eccentricity, only  11 
fixations around the origin were included in the analysis. Fixation was compared between groups 12 
using 10 measures (see Table 6). 13 
 14 
*** Insert Table 6 Here *** 15 
 16 
 No differences were found using either parametric or non-parametric methods. Additionally, no 17 
results were found running parametric tests on log transformed data, which was closer to 18 
normally distributed. 19 
 20 
Discussion 21 
Diagnosing and monitoring recovery after mTBI, using either subjective or objective parameters, 22 
is challenging.  Importantly, the study revealed significant differences in a number of eye 23 
14 
 
tracking components, both for tasks involving a step displacement of the target and for smooth 1 
pursuit tasks. Uncovering these differences represents a vital initial step towards development of 2 
objective tests which can discriminate between individuals with symptomatic mTBI and controls. 3 
This investigation represents the first examination of the utility of eye tracking to identify 4 
objective findings in individuals with subjective symptoms after mTBI using a non-mTBI control 5 
group for comparison. Given the challenges of both diagnosing and monitoring recovery after 6 
mTBI, using either subjective or objective parameters, this study represents a significant step 7 
forward.  8 
Importantly, we found significant differences in two of the three eye tracking parameters 9 
studied: saccades and SPEM. Robust differences were found between responses of subjects with 10 
symptomatic mTBI and controls to horizontal and vertical stepwise target displacement tasks, 11 
with subjects with symptomatic mTBI having statistically larger position errors, smaller saccadic 12 
amplitudes, smaller predicted peak velocities, smaller peak accelerations, and longer durations. 13 
Subjects with symptomatic mTBI were also more likely to respond to step changes in target 14 
position with smaller primary saccades compared to controls. In general, symptomatic mTBI 15 
tracked the stepwise moving targets less accurately, revealing possible brain dysfunction. This 16 
investigation represents the first examination of the utility of eye tracking using a non-mTBI 17 
control group as a means to identify objective findings in individuals with subjective symptoms 18 
after mTBI.   Differences in responses to smooth pursuit tasks were also found between subject 19 
groups, although not as robust as the differences between mTBI subjects and controls. Here, the 20 
saccadic amplitudes were significantly different.  The amplitudes were larger for subjects with 21 
symptomatic mTBI for the horizontal smooth pursuit task.  In comparison to controls, pursuit 22 
gain was lower among subjects with symptomatic mTBI. Surprisingly, in contrast to a number of 23 
15 
 
other neurological disorders, no differences were found between groups for fixation measures.  1 
Further investigation into the specificity and sensitivity of these measures in light of the often 2 
complex polytraumatic nature of individuals with either combat or civilian-related injury (e.g., 3 
presence of acute or chronic conditions, anxiety disorders, depression, pain and substance abuse) 4 
is warranted. This represents an important initial step in the understanding of the role of both eye 5 
movement abnormalities and computerized eye tracking in the diagnosis and monitoring of 6 
symptomatic mTBI. Specific linkages between symptoms, eye tracking abnormalities, and 7 
neuropathology (as revealed by neuroimaging) may be an important subsequent step. 8 
The wide array of abnormalities uniquely found in the mTBI cohort may have 9 
contributed to their diverse complaints, including headache, blurred/double vision, dizziness, 10 
clumsiness, reading difficulties, and driving problems. Future studies correlating the magnitude 11 
and type of the range of eye movement errors with ecologic complaints would be a fruitful area 12 
of further investigation. These analyses could also assist in the development of both predictive 13 
models for symptom development and recovery, and in the development of effective treatments 14 
for specific symptom-eye tracking abnormality associations.  15 
This study utilized standard protocols to define exposure to a PCE, to be symptomatic for 16 
PCS, and for eye tracking, which allowed us to remove much of the subjectively commonly 17 
encountered in mTBI research. However there were some limitations to the research design that 18 
may limit its generalizability. These include; gender, restricted age, etiology of mTBI, chronicity 19 
of mTBI and symptoms, variability in symptom treatments, and co-morbid conditions. These 20 
restrictions may be less significant, in particular to the Departments of Defense and Veterans 21 
Affairs systems, since the bulk of individuals with mTBI seen in these systems tend to be 22 
younger males with complex military theatre polytrauma injuries.
29
 Future studies will focus on 23 
16 
 
larger samples of individuals that include cohorts with more discrete causes of symptom 1 
complex (e.g., isolated mTBI, isolated stress disorders, isolated pain complaints), in an attempt 2 
to identify unique patterns of eye movement abnormalities based on etiology of symptoms. 3 
Additionally, analyses of the impact of symptom patterns on eye movement seen, as well as the 4 
association between differential patterns of eye movement abnormalities with symptom 5 
presentations, can be performed with larger subject samples. Lastly, temporal associations 6 
between injury, symptom presentation, and eye movement abnormalities may be an important 7 
key to use of eye tracking to monitor recovery after mTBI. 8 
9 
17 
 
References 1 
1. http://newsfeed.time.com/2013/06/19/head-trauma-sensors-aim-to-measure-concussion-2 
risks/; http://www.thedailybeast.com/newsweek/2010/11/08/ 3 
2. http://www.thedailybeast.com/newsweek/2010/11/08/veteran-s-head-injuries-confound-4 
military-doctors.html 5 
3. http://www.healthquality.va.gov/Rehabilitation_of_Concussion_mTBI.asp 6 
 7 
4. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. N Engl J Med 2008; 8 
358:453-463. 9 
 10 
5. Brenner LA, Vanderploeg RD,Terrio H. Assessment and diagnosis of mild traumatic 11 
brain injury, posttraumatic stress disorder, and other polytrauma conditions: Burden of 12 
adversity hypothesis. Rehabil Psych 2009;54(3):239-246. 13 
 14 
6. ICD-10, International Statistical Classification of Diseases and Related Health Problems 15 
10th Revision (ICD-10) Version for 2010, F07.2 Postconcussional syndrome, World 16 
Health Organization. 17 
 18 
7. Arciniegas DB, Topkoff JL. Applications of the P50 evoked response to the evaluation of 19 
cognitive impairments after traumatic brain injury. Phys Med Rehabil Clin N Am 2004 20 
Feb;15(1):177-203. 21 
8. Gosselin N, Bottari C, Chen JK, Petrides M, Tinawi S, de Guise E, Ptito A. 22 
Electrophysiology and functional MRI in post-acute mild traumatic brain injury. J 23 
Neurotrauma 2011;28(3):329-41.  24 
9. Nuwer MR, Hovda DA, Schrader LM, Vespa PM Routine and quantitative EEG in mild 25 
traumatic brain injury. Clin Neurophysiol 2005;116(9):2001-25. 26 
10. Cohen BA, Inglese M, Rusinek H, Babb JS, Grossman RI, Gonena O. MR Spectroscopy 27 
and MRI-Volumetry in Mild Traumatic Brain Injury. AJNR 2007;28:907-913. 28 
11. McAllister TW, Saykin AJ, Flashman LA, Sparling MB, Johnson SC, Guerin SJ, 29 
Mamourian AC, Weaver JB, Yanofsky N. Brain activation during working memory 1 30 
month after mild traumatic brain injury: a functional MRI study. Neurol 31 
1999;53(6):1300-8. 32 
12. Yuh EL, Mukherjee P, Lingsma HF, Yue JK, Ferguson AR, Gordon WA, Valadka AB, 33 
Schnyer DM, Okonkwo DO, Maas AI, Manley GT; TRACK-TBI Investigators. Magnetic 34 
resonance imaging improves 3-month outcome prediction in mild traumatic brain injury. 35 
Ann Neurol 2013 Feb;73(2):224-35.  36 
13. Buxton RB, Uludağ K, Dubowitz DJ, Liu TT. Modeling the hemodynamic response to 37 
brain activation. Neuroimage 2004;23 Suppl 1:S220-33. 38 
18 
 
14. Deppe M, Ringelstein EB, Knecht S. The investigation of functional brain lateralization 1 
by transcranial Doppler sonography. Neuroimage 2004;21(3):1124-46. 2 
15. Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue 3 
oxygenation Br J Anaesth 2009;103 (suppl 1): i3-i13. 4 
16. Pickett TC, Radfar-Baublitz LS, McDonald SD, Walker WC, Cifu DX. Objectively 5 
assessing balance deficits after TBI: Role of computerized posturography. J Rehabil Res 6 
Dev 2007;44(7):983-90. 7 
17. Guskiewicz KM, Ross SE, Marshall SW. Postural Stability and Neuropsychological 8 
Deficits After Concussion in Collegiate Athletes. J Athl Train 2001;36(3):263-273. 9 
18. Brenner LA, Terrio H, Homaifar BY, Gutierrez PM, Staves PJ, Harwood JE, Reeves D, 10 
Adler LE, Ivins BJ, Helmick K, Warden DF. Neuropsychological test performance in 11 
soldiers with blast-related mild TBI. Neuropsychol 2010;24(2):160-7.  12 
19. Ceranic B, Prasher D, Raglan E, Luxon L. Tinnitus after head injury: evidence from 13 
otoacoustic emissions J Neurol Neurosurg Psychiatry 1998; 65(4): 523–529 14 
20. http://www.dcoe.health.mil/Content/navigation/documents/Portable%20Field-15 
Based%20Devices%20for%20the%20Early%20Diagnosis%20of%20mTBI.pdf 16 
21. Kraus MF, Little DM, Donnell AJ, Reilly JL, Simonian N, Sweeney JA.  Oculomotor 17 
Function in Chronic Traumatic Brain Injury.  Cog Behav Neurol. 2007; 20(3): 170-178.  18 
PMID:17846516 19 
22. Heitger MH, Jones RD, Anderson TJ.  A new approach to predicting postconcussion 20 
syndrome after mild traumatic brain injury based upon eye movement function.  Conf 21 
Proc IEEE Eng Med Biol Soc. 2008; 2008:3570-3.  doi: 10.1109/IEMBS.2008.4649977 22 
23. Ciuffreda, LLudlam D, Thiagarajan P.  Oculomotor diagnostic protocol for the mTBI 23 
population.  Optometry. 2011; 82(2): 61-63.  doi: 10.1016/j.optm.2010.11.011.   24 
24. Ramat S, Leigh RJ, Optican LM.  What clinical disorders tell us about the neural control 25 
of saccadic eye movements. Brain. 2007; 130: 10-35.  doi: 10.1093/brain/awl309. 26 
25. Suh M, Kolster R, Sarkar R, McCandliss B, Ghajar J, Cognitive and Neurobiological 27 
Research Consortium.  Deficits in predictive smooth pursuit after mild traumatic brain 28 
injury.  Neurosci Lett. 2006; 401(1-2): 108-113.  doi: 10.1016/j.neulet.2006.02.074. 29 
26. Cifu DX, Hart BB, West SL, Walker WC, et al. The effect of hyperbaric oxygen on 30 
persistent post-concussive symptoms. J Head Trauma Rehabil. doi: 31 
10.1097/HTR.0b013e3182a6aaf0 32 
27. Eyres S, Carey, A, Gilworth, G., Neumann V,  Tennant, A. Construct validity and 33 
reliability of the Rivermead post-concussion symptoms questionnaire. Clinical Rehabil 34 
2005 19(8), 878-887  35 
19 
 
28. Leigh, R. John, Zee, David S.  The Neurology of Eye Movements, Oxford University 1 
Press:2006. 2 
29. Cifu DX, Blake P: Overcoming Post-Deployment Syndrome: A Six-Step Mission to 3 
Health. DemosHealth, New York, 2011. 4 
  5 
20 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
Table 1 9 
Measures for Comparing Saccadic Data 10 
 11 
Number of Primary Saccades: the number of times the subject made at least one 
saccadic movement following a target movement (if target moved again before the 
subject then no primary saccade was recorded) 
Number of correcting saccades: the total number of saccades excluding the primary 
saccades following the target movements 
Average Latency: the mean reaction time to each target movement  
Primary Position Error: the absolute value of the difference between the target 
displacement and the amplitude of the primary saccades.  Three sub-measures of primary 
position error were calculated:  
 Mean of the Normalized Position Error. the mean of the absolute value of the 
ratio between the position error and the target amplitude. Normalization attempts to 
account for the dependency of the amplitude of the position error on the amplitude 
of the target displacement.  
 Standard Deviation of the Ratios of the Position Error and the Target 
Displacement. 
 Mean of the Absolute Value of the Non-normalized Position Errors. 
Final Position Error: the absolute value of the difference between the target 
displacement and the position of the eye before the next target movement. The same three 
sub-measures for primary position error were calculated for final position error. 
Mean of the Absolute Value of the Normalized Primary Saccadic Amplitude: the 
mean of the absolute value of the ratio between the primary saccadic amplitude and the 
target amplitude for all saccades per individual. Here, normalization attempts to account 
for the dependency of the amplitude of the primary saccades on the amplitude of the 
target displacement. 
Mean Q-Ratio: the mean of the ratio between peak velocity and saccadic amplitude over 
all saccades per individual. 
 12 
  13 
21 
 
 1 
 2 
 3 
 4 
 5 
Table 2 6 
Horizontal Displacement Task 7 
 8 
 
HORIZONTAL 
TRACKING 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Type of test* 
Mean of normalized 
primary position error 
.4255 .2043 .000 nonparametric 
SD of normalized 
primary position error 
.6993 .3502 .000 nonparametric 
Mean of normalized 
final position error 
.2993 .1346 .016 nonparametric 
Mean of non-
normalized primary 
position error 
4.7572 2.3803 .000 nonparametric 
Number of primary 
saccades 
20.64 24.92 .000 nonparametric 
Predicted Velocity, 1-
deg amp 
55.4612 59.4678 .008 parametric 
Predicted Velocity, 5-
deg amp 
219.71 235.51 .001 parametric 
Predicted Acceleration, 
1-deg amp 
3464.97 3712.18 .026 parametric 
Predicted Acceleration, 
5-deg amp 
12495.4 13530.74 .003 parametric 
Predicted Duration, 1-
deg amp 
36.60 34.71 .000 nonparametric 
Predicted Duration, 5-
deg amp 
61.62 56.93 .000 nonparametric 
CAPTION:  55 Group A and 26 Group B had complete results for all of the horizontal target displacement 9 
tasks 10 
 11 
*In all cases in this table, the employment of nonparametric rather than parametric tests did not affect whether the 12 
difference between groups was significant. 13 
  14 
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Table 3 6 
Vertical Displacement Task 7 
 8 
VERTICAL 
TRACKING 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Type of test* 
Mean of normalized 
primary position error 
.4093 .2523 .002 parametric 
SD of normalized 
primary position error 
.5737 .3416 .011 nonparametric 
Mean of normalized 
final position error 
.3184 .1817 .004 parametric 
Mean of non-
normalized primary 
position error 
3.0513 1.9616 .054* parametric 
Number of primary 
saccades 
22.74 24.72 .000 nonparametric 
Predicted Velocity, 1-
deg amp 
52.61 58.94 .000 parametric 
Predicted Velocity, 5-
deg amp 
213.5 229.9 .001 parametric 
Predicted Acceleration, 
1-deg amp 
3121.93 3508.92 .000 parametric 
Predicted Acceleration, 
5-deg amp 
11714.6 12906.8 .000 nonparametric 
Predicted Duration, 1-
deg amp 
39.36 35.97 .000 parametric 
Predicted Duration, 5-
deg amp 
66.67 59.78 .000 nonparametric 
CAPTION: 47 Group A and 26 Group B had complete results for all of the vertical target displacement 9 
tasks. 10 
 11 
*In all cases in this table, the employment of nonparametric rather than parametric tests did not affect whether the 12 
difference between groups was significant. 13 
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Table 4 7 
Measures for Comparing Smooth Pursuit Data 8 
 9 
Number of Saccades: the total number of saccades during a smooth pursuit task 
Mean Gain: the mean of the ratios of eye velocity and target velocity between saccades 
Minimum Gain: the minimum of the ratios of eye velocity and target velocity between 
saccades 
Maximum Gain: the maximum of the ratios of eye velocity and target velocity between 
saccades 
Mean Absolute Saccadic Amplitude: the mean of the absolute value of saccadic 
amplitude calculated across all saccades during the tasks 
Mean Duration: the mean length of time eyes are smoothly pursuing the target between 
saccades 
Mean Absolute Normalized Saccadic Amplitude: the mean of the absolute value of the 
ratio of saccadic amplitude and target velocity. Normalization by target velocity attempts 
to account for dependency of saccadic amplitude on the velocity of the target. 
 10 
  11 
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Table 5 7 
Smooth Pursuit Ramp Data 8 
 9 
HORIZONTAL 
RAMP 
Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Min Gain .0804 .1088 .000 
Mean normalized 
amplitude 
.2208 .1561 .017 
 10 
VERTICAL RAMP Mean Group 
A 
Mean Group 
B (control) 
Significance 
Level 
Min Gain .0761 .1013 .011 
Mean normalized 
amplitude 
.2253 .2933 .016 
CAPTION: 55 Group A and 24 Group B had complete results for all of the horizontal smooth 11 
pursuit tasks; 49 Group A and 23 Group B had complete results for all of the vertical smooth pursuit 12 
tasks 13 
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Figure 1 1 
Sample Model Fits 2 
 3 
.. 4 
Caption: Example model fits for an individual subject.  Peak Velocity, Acceleration and Duration versus Saccadic 5 
Amplitude (Top, Middle and Bottom, respectively). The blue dots represent absolute values of data recorded from a 6 
horizontal step displacement task. The red lines are the corresponding model fits. 7 
